Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Lanxess squeezes Chemtura costs
by Alex Scott
September 11, 2017
| A version of this story appeared in
Volume 95, Issue 36
Lanxess expects to save $120 million per year by 2020 from its recent acquisition of Chemtura. The firm had previously anticipated savings of about $100 million. Lanxess expects to reap half the savings from synergies in production and procurement, including the optimization of Chemtura processes and technologies. About 30% of savings are expected to come from cuts in administrative costs, primarily in North America. The final 20% will come from streamlining the combined sales and marketing organization. Lanxess has not revealed the impact on jobs.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X